Arcutis Director Sells $121,000 Amid ZORYVE Revenue Surge
A biotech insider sale of about $121,000 sits beside a strong ZORYVE revenue story. This article breaks down what it ...
Uncover various ways to access cash for debt repayment that can streamline your path to financial stability. Explore your options today.
22,799 articlesA biotech insider sale of about $121,000 sits beside a strong ZORYVE revenue story. This article breaks down what it ...
Palantir shares slip in a broad software selloff, brushing near key support as investors weigh growth prospects again...
A widespread fraud targeted older Americans by posing as Publishers Clearing House winners. Federal investigators say...
Coinbase is posting a down year as crypto markets swing and competition intensifies. As of late June 2026, COIN trade...
XRP’s derivatives market shows a rare drop in open interest while large holders accumulate on-chain. The move could h...
Tesla stock has rebounded in recent sessions, creating a balanced risk-reward outlook as markets await the Q2 deliver...
Microsoft's Xbox unit is cutting 3,200 jobs as part of a sweeping overhaul aimed at refocusing on the console and cor...
Ethereum steadies as a $2.5 billion Tether burn on the Ethereum network prompts traders to weigh liquidity moves agai...
Earnings beats aren’t enough to steady markets as stocks see bigger, more persistent swings. The article explains wha...
When Wells Fargo reports earnings, the spotlight isn’t just on per-share figures. The real story this quarter is net ...
IBM shares plunged after a softer than expected Q2 outlook, triggering a sharp one day drop. Analysts remain split, w...
TSMC delivers a record quarterly print as AI-driven demand powers growth. Margin expands and 2026 guidance rises, sig...